21st Austria weekly - Immofinanz (04/09/2024)

Immofinanz: Austrian based real estate company IMMOFINANZ AG and its core shareholder CPI Property Group SA (“CPIPG”) have agreed upon to enter into negotiations for the acquisition of the remaining shares in S IMMO AG by IMMOFINANZ. Currently, IMMOFINANZ directly holds approx. 50.60% of S IMMO and CPIPG directly holds 38.37%. The potential transaction would involve 28,241,094 shares in S IMMO (approx. 38.37%) as CPIPG's remaining stake in S IMMO. A transaction would take place at a fair market price taking into account as an upper limit the cash compensation of EUR 22.05 per share to be paid to the minority shareholders of S IMMO pursuant to the initiated squeeze-out procedure and a discount to be negotiated. CPIPG is expected to provide long-term financing to IMMOFINANZ for a portion of the purchase price. Upon completion of a purchase and the squeeze-out IMMOFINANZ would be 100% shareholder of S IMMO.
Immofinanz: weekly performance: -21.24%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (04/09/2024)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #759: ATX Murmeltiermodus, Frequentis lädt Private zum CEO-Talk und A Message to you Rudi Fußi

Bildnachweis

1. Immofinanz, Stop Shop, PV-Anlagen, Foto: Immofinanz , (© Aussender)   >> Öffnen auf photaq.com

Aktien auf dem Radar:Porr, voestalpine, Addiko Bank, Austriacard Holdings AG, CA Immo, Amag, VIG, Erste Group, Verbund, SBO, Wienerberger, Andritz, Polytec Group, Cleen Energy, EuroTeleSites AG, Flughafen Wien, Josef Manner & Comp. AG, Marinomed Biotech, Pierer Mobility, Stadlauer Malzfabrik AG, Agrana, EVN, Österreichische Post, S Immo, Telekom Austria, Uniqa, Warimpex.

Random Partner

---

Evotec
Evotec ist ein Wirkstoffforschungs- und -entwicklungsunternehmen, das in Forschungsallianzen und Entwicklungspartnerschaften mit Pharma- und Biotechnologieunternehmen, akademischen Einrichtungen, Patientenorganisationen und Risikokapitalgesellschaften Ansätze zur Entwicklung neuer pharmazeutischer Produkte vorantreibt.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner